Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 7, 2017, Pages

  Juthani, Viral V ^a   Clearfield, Elizabeth ^b   Chuck, Roy S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE OUTCOME; BEST CORRECTED VISUAL ACUITY; CATARACT EXTRACTION; COMPARATIVE EFFECTIVENESS; CORNEA EDEMA; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EYE INFLAMMATION; HUMAN; INTRAOCULAR PRESSURE; MONOTHERAPY; PHACOEMULSIFICATION; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA CYSTOID EDEMA; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADVERSE EFFECTS; COMBINATION DRUG THERAPY; CORNEAL EDEMA; EYE DISEASES; INFLAMMATION; MACULAR EDEMA; META ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; VISUAL ACUITY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATARACT EXTRACTION; CORNEAL EDEMA; DRUG THERAPY, COMBINATION; EYE DISEASES; HUMANS; INFLAMMATION; MACULAR EDEMA; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISUAL ACUITY;

EID: 85021691776     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010516.pub2     Document Type: Review

References (150)

1. Adam R, Rodallec T, Nordmann JP. Indometacine and macular thickness undergoing cataract surgery: a prospective randomized study. Investigative Ophthalmology & Visual Science 2005; Vol. 46:E-Abstract 787. 5774951
2. Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. Journal of Cataract and Refractive Surgery 2008;34(1):64-9. 5774953
3. Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Journal of Cataract and Refractive Surgery 2012;38(9):1537-43. 5774955
4. Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, et al. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasonone 0.1%. Journal of Cataract and Refractive Surgery 2008;31(1):57-63. 5774957
5. Bucci FA, Matta AZ. An objective comparison of acular vs vexol to control inflammation following phacoemulsification. American Academy of Ophthalmology; 2001 Nov 11-14; New Orleans (LA). 2001:117. 5774959
6. Cervantes-Coste G, Sánchez-Castro Y, Orozco-Carroll M, Mendoza-Schuster E, Velasco-Barona C. Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clinical Ophthalmology 2009;3(1):219-26. 5774961
7. Chatziralli IP, Papazisis L, Sergentanis TN. Ketorolac plus tobramycin/dexamethasone versus tobramycin/dexamethasone after uneventful phacoemulsification surgery: a randomized controlled trial. Ophthalmologica 2011;225(2):89-94. 5774963
8. Chatziralli IP, Sergentanis TN, Parikakis EA, Papazisis LE, Mitropoulos P, Moschos MM. The impact of non-steroidal anti-inflammatory agents after phacoemulsification on quality of life: a randomized study. Ophthalmology and Therapy 2017;6(1):133-40. 5774964
9. Chen J, Wang GQ. Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery. International Eye Science 2015;15(12):2102-4. 5774966
10. Dal D, Saraç O, Toklu Y, Cakmak HB, Gungor ED. Efficacy of topical ketoroloc on macular thickness in patients undergoing cataract surgery. Ophthalmologica 2014;232(Suppl 2):43. 5774968
11. Demco TA. Topical diclofenac versus prednisolone acetate in control of inflammation after phacoemulsification. American Academy of Ophthalmology 1995:150. 5774971
12. Demco TA, Sutton H, Demco CJ, Raj PS. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. European Journal of Ophthalmology 1997;7(3):236-40. 5774970
13. Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. Journal of Cataract and Refractive Surgery 2006;32(9):1474-82. 5774973
14. Duong HV, Westfield KC, Singleton IC. Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Acta Ophthalmologica 2015;93(4):e314-5. 5774975
15. Duong HV, Westfield KC, Singleton IC. Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation. Asia-Pacific Journal of Ophthalmology 2014;3(4):220-5. 5774976
16. el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surgery and Lasers 1998;29(7):539-44. 5774978
17. Elsawy MF, Badawi N, Khairy HA. Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology 2013;7:1245-9. 5774980
18. Endo N, Kato S, Haruyama K, Shoji M, Kitano S. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. Acta Ophthalmologica 2010;88(8):896-900. 5774982
19. Kitano S, Endo N, Shoji M, Haruyama K, Kato S. Effect of bromfenac sodium ophthalmic solution on preventing cystoids macular edema and inflammation after phacoemulsification and implantation of intraocular lens in diabetic patients. Investigative Ophthalmology & Visual Science 2008; Vol. 49:ARVO E-Abstract 3470. 5774983
20. Entezari M, Ramezani A, Nikkhah H, Yaseri M. The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology 2017;37(1):13-8. [DOI: 10.1007/s10792-016-0209-4]5774985
21. Guzey M, Karadede Z, Dogan Z, Satici A. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. Ophthalmic Surgery and Lasers 2000;31(6):451-6. 5774987
22. Hessemer V, Schartner H. Low influence of anti-inflammatory therapy on intraocular inflammation following minimally invasive phacoemulsification [Geringer Einfluß antiinflammatorischer Therapie auf den intraokularen Reizzustand nach minimal invasiver Phakoemulsifikation]. Der Ophthalmologe 1997;94(1):30-2. 5774989
23. Hessemer V, Schmidt K, Schartner H. Minimally inflammatory cataract surgery [Minimal inflammatorische Kataraktchirurgie (MIK)]. Klinische Montasblätter für Augenheilkunde 1996;209(6):331-9. 5774990
24. Holzer MP, Solomon KD, Sandoval HP, Vroman DT. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification. Journal of Cataract and Refractive Surgery 2002;28(1):93-9. 5774992
25. Jung JW, Chung BH, Kim EK, Seo KY, Kim TI. The effects of two non-steroidal anti-inflammatory drugs, bromfenac 0.1% and ketorolac 0.45%, on cataract surgery. Yonsei Medical Journal 2015;56(6):1671-7. 5774994
26. Kato S, Boku C, Onishi T, Koike M, Kageyama T, Nishihara H, et al. Comparison of postoperative inflammation with two types of intraocular lense and anti-inflammatory agents. Folia Ophthalmologica Japonica 1998;49:286-9. 5774996
27. Laurell CG, Zetterström C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. British Journal of Ophthalmology 2002;86(12):1380-4. 5774998
28. Li MC, Yang XR, Liu F, Shao DP, Li YB. Effect of topical NSAIDs in preventing macular edema after phacoemulsification in diabetes. International Journal of Ophthalmology 2011;11(9):1614-6. 5775000
29. Aschbrenner MW, Mathys KC, Cohen KL. Do biological parameters and phaco metrics affect OCT measured CMT with and without nepafenac 0.1% treatment?. Investigative Ophthalmology & Visual Science 2008;49(13):389. 5775002
30. Mathys KC, Cohen KL. Effect of nepafenac on macular thickness following uncomplicated cataract surgery. Investigative Ophthalmology & Visual Science 2008; Vol. 49:ARVO E-Abstract 5674. 5775003
31. Mathys KC, Cohen KL. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Eye 2010;24(1):90-6. 5775004
32. McColgin AZ, Raizman MB. Efficacy of topical voltaren in reducing the incidence of postoperative cystoid macular edema. Investigative Ophthalmology & Visual Science 1999; Vol. 40:ARVO E-Abstract 1529. 5775006
33. Miyake K, Nishimura K, Harino S, Ota I, Asano S, Kondo N, et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Investigative Ophthalmology & Visual Science 2007;48(12):5647-52. 5775008
34. Miyake K, Ota I, Miyake G, Numaga J. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery 2011;37(9):1581-8. 5775010
35. Miyanaga M, Miyai T, Nejima R, Maruyama Y, Miyata K, Kato S. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica 2009;87(3):300-5. 5775012
36. Moschos MM, Chatziralli IP, Pantazis P, Rouvas AA, Sergentanis TN. Is topical diclofenac essential before and after uneventful phacoemulsification cataract surgery?. Journal of Ocular Pharmacology and Therapeutics 2012;28(4):335-9. 5775014
37. Mulet ME, Alio JL, Ayala MJ, De la Hoz F, Beda JL. Efficacy of 0.5% ketorolac (Acular™) as an anti-inflammatory treatment after cataract surgery. Investigative Ophthalmology & Visual Science 2001;42:ARVO E-Abstract 66. 5775016
38. Ostrov CS, Sirkin SR, Deutsch WE, Masi RJ, Chandler JW, Lindquist TD. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clinical Therapeutics 1997;19(2):259-72. 5775018
39. Brennan KM, Brown RM, Roberts CW. A comparison of topical non-steroidal anti-inflammatory drugs to steroids for control of post cataract inflammation. Journal of the American Society of Ophthalmic Registered Nurses 1993;18(1):8-11. 5775020
40. Brown RM, Roberts CW. Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Journal of the American Society of Ophthalmic Registered Nurses 1996;21(1):13-6. 5775021
41. Roberts CW. A comparison of non-steroidal anti-inflammatory drug to steroids for postoperative inflammation. American Academy of Ophthalmology 1992; Vol. 22. 5775023
42. Roberts CW, Brennan KM. A comparison on topical diclofenac with prednisolone for postcataract inflammation. Archives of Ophthalmology 1995;113(6):725-7. 5775022
43. Rodríguez YR, PereraII YM, Hernández IM, ÁvilaII RI, Hernández Silva JR, Ochoa MJ. Diclofenac sodium eyedrops in cataract's surgery by phacoemulsification [Colirio de diclofenaco sódico en cirugía de catarata por facoemulsificación]. Revista Cubana de Oftalmología 2011;24(1):46-54. 5775025
44. Sahu S, Ram J, Bansal R, Pandav SS, Gupta A. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Journal of Cataract and Refractive Surgery 2015;41(10):2043-8. 5775027
45. Schmitt TH. Anti-inflammatory therapy after cataract surgery - a laser-flare-cell photometer controlled study [Zur antiinflammatorischen therapie nach kataraktchirurigie. Eine kontrollierte studie mittels Laser-Flare-Cell-Photometrie]. Aktuelle Augenheilkunde 1995;20(5):263-8. 5775029
46. Shimazaki J, Fujishima H, Yagi Y, Tsubota K. Effects of diclofenac eye drops on corneal epithelial structure and function after small-incision cataract surgery. Ophthalmology 1996;103(1):50-7. 5775031
47. Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clinical Ophthalmology 2012;2012(6):1259-69. 5775033
48. Solomon KD, Vroman DT, Barker D, Gehlken J. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Journal of Cataract and Refractive Surgery 2001;27(8):1232-7. 5775035
49. Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial. Journal of Ocular Pharmacology and Therapeutics 2014;30(6):495-501. 5775037
50. Trinavarat A, Atchaneeyasakul L, Surachatkumtonekul T, Kosrirukvongs P. Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. Journal of the Medical Association of Thailand 2003;86(2):143-50. 5775039
51. Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, et al. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. British Journal of Ophthalmology 2015;99(5):654-8. 5775041
52. Voudouri A, Zafirakis P, Livir-Rallatos G, Livir-Rallatos C, Canakis C, Markomichelakis N. Diclofenac versus prednisolone post phacoemulsification treatment: a randomized clinical trial. Investigative Ophthalmology & Visual Science 2002; Vol. 43:ARVO E-Abstract 373. 5775043
53. Wang QW, Yao K, Xu W, Chen PQ, Shentu XC, Xie X, et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica 2013;229(4):187-94. 5775045
54. Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. American Journal of Ophthalmology 2008;146(4):554-60. 5775047
55. Yavas GF, Oztürk F, Küsbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery 2007;33(5):804-7. 5775049
56. Zaczek A, Artzen D, Laurell CG, Stenevi U, Montan P. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. Journal of Cataract and Refractive Surgery 2014;40(9):1498-505. 5775051
57. Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian Journal of Ophthalmology 2012;60(4):277-81. 5775053
58. Zhang HY, Zhu SQ. Clinical study of pranoprofen eyedrops on prophylaxis of cystoids macular edema after cataract surgery. International Journal of Ophthalmology 2008;8(7):1370-2. 5775055
59. Abelson MB, Smith LM, Ormerod LD. Prospective, randomized trial of oral piroxicam in the prophylaxis of postoperative cystoid macular edema. Journal of Ocular Pharmacology 1989;5(2):147-53. 5775057
60. Bahar I, Rosenblat I, Erenberg M, Eldar I, Gaton D, Avisar R, et al. Effect of dexamethasone eyedrops on blood glucose profile. Current Eye Research 2007;32(9):739-42. 5775059
61. Barequet IS, Wygnanski-Jaffe T, Sachs D. Effect on posterior capsule opacification of topical diclofenac sodium vs dexamethasone phosphate after cataract surgery. Annals of Ophthalmology 2002;34(2):142-7. 5775061
62. Barequet IS. Posterior capsule opacification: The effect of postoperative topical therapy with Voltaren vs. Maxidex after cataract surgery. American Academy of Ophthalmology 1999, issue AAO abstract 244. 5775064
63. Barequet IS, Wygnanski-Jaffe T, Sachs D. Effect of diclofenac versus dexamethasone on posterior capsule opacification. Journal of Cataract and Refractive Surgery 2004;30(11):2253-4. 5775063
64. Burde RM, Waltman SR. Topical corticosteroids after cataract surgery. Annals of Ophthalmology 1972;4(4):290-3. 5775066
65. Carenini BB, Brancato R, De Molfetta V, Frezzotti R, Balestrazzi E, Cardia L, et al. Indomethacin ophthalmic suspension in the prevention of cystoid macular oedema in cataract extraction patients [L'Indometacina, sospensione oftalmica, nella prevenzione dell'edema maculare cistoide in pazienti sottoposti ad estrazione di cataratta]. Annali di Ottalmologia e Clinica Oculistica 1993;119(9):681-7. 5775068
66. Chang A, Arnold J, Davies P, Heriot W, Adewale A, Jaross N. Efficacy and safety of nepafenac 0.3% ophthalmic suspension administered once-daily in patients with diabetic retinopathy following cataract surgery. Clinical and Experimental Ophthalmology 2016;44(Suppl 1):57-8. 5775070
67. Corbett MC, Hingorani M, Boulton JE, Shilling JS. Subconjunctival betamethasone is of benefit after cataract surgery. Eye 1993;7(6):744-8. 5775072
68. EUCTR2009-017031-18-NL. Treatment of cystoid macular edema following cataract surgery. A randomized, double-masked, placebo-controlled, clinical trial - treatment of post-cataract CME. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-017031-18-NL (accessed 5 October 2016). 5775074
69. EUCTR2015-003296-30-FI. Efficacy of steroid and nonsteroidal anti-inflammatory eye drops in management of post-operative inflammation and prevention of pseudophakic cystic macular edema after uncomplicated cataract surgery. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2015-003296-30-FI (accessed 5 October 2016). 5775076
70. Farooq Q, Ali SI. Comparison of anti-inflammatory activity of ofloxacin + dexamethasone eye drops and flurbiprofen eye drops in post operative cases. Pakistan Journal of Ophthalmology 2003;19(4):122-9. 5775078
71. Ferreira PC, Bauer Koerich LC, Lima GS, Ramalho F, Figueiredo AM. Influence of prednisolone acetate 1% and ketorolac 0.5% eyedrops in endothelial cell loss after cataract surgery. American Academy of Ophthalmology; 2006 Nov 11-14; Las Vegas (NV). 2006. 5775080
72. Hessemer V, Schmitt K. Local treatment with steroids and/or non-steroid antiphlogistic agents in cataract surgery? A lasertyndallometric answer [Lokaltherapie mit Steroiden und/oder nichtsteroidalen Antiphlogistika in der Kataraktchirurgie? Eine lasertyndallometrische Antword]. Klinische Monatsblatter Fur Augenheilkunde 1994;204:186. 5775082
73. Hossain MM, Mohiuddin AA, Hossain MA, Aziz MA. Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. Mymensingh Medical Journal 2010;19(3):343-7. 5775084
74. Hosseini K, Walters T, DaVanzo R, Lindstrom RL. A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects. Clinical Ophthalmology 2016;10:2311-7. 5775086
75. ISRCTN02628492. Prevention of pseudophakic cystoid macula oedema with pre- and post-operative ketorolac. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN02628492 (accessed 5 October 2016). 5775088
76. Knopf MM. A double-blind study of fluorometholone. American Journal of Ophthalmology 1970;70:739-40. 5775090
77. Kraff MC, Sanders DF, McGuigan L, Raanan MG. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. Archives of Ophthalmology 1990;7(1):380-3. 5775092
78. Liou SW, Yen RJ. The effect of 0.1% indomethacin eyedrops on cataract surgery. Journal of Ocular Pharmacology 1991;7(1):77-81. 5775094
79. Luo Y, Feng J, Lu M, Cheng XK. Clinical assessment of diclofenac sodium eye drops in toric intraocular lens implantation. International Eye Science 2013;13(5):880-2. 5775096
80. Maheshwari R, Ather M, Bhandari V. A study on comparative efficacy of topical non-steroidal anti inflammatory drug, flurbiprofen and corticosteroids in post operative ocular inflammation. Afro-Asian Journal of Ophthalmology 1995;14(1):12-4. 5775098
81. McDonald MB, Schanzlin D. Diclofenac Sodium (DS) versus Prednisolone Acetate (PA) in the treatment of inflammation following cataract extraction. American Academy of Ophthalmology 1998:147. 5775100
82. Meconi S, Scorolli L, Scalinci SZ, Massimi M, Meduri R. A comparison of topical diclofenac with indomethacin for post-phacoemulsification CME (cystoid macular edema) [Comparazione dell'utilizzo del diclofenac e dell'indometacina nell'emc post-facoemulsificazione]. Annali di Ottolmaologia e Clinica Oculistica 1998;124(11-12):357-65. 5775102
83. Missotten L, Richard C, Trinquand C. Topical 0.1% indomethacin solution versus topical 0.1% dexamethasone solution in the prevention of inflammation after cataract surgery. Ophthalmologica 2001;215(1):43-50. 5775104
84. Miyake K, Masuda K, Shirato S, Oshika T, Equchi K, Hoshi H, et al. Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema. Nippon Ganka Gakkai Zasshi 1998;102(8):522-30. 5775106
85. Miyake K, Masuda K, Shirato S, Oshika T, Egucha K, Hoshi H, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Japanese Journal of Ophthalmology 2000;44(1):58-67. 5775108
86. Mullins A, Meijer P, Airey R, Gunda P, Banhazi J. Cost-effectiveness of nepafenac 3 mg/ml for the reduction in risk of post-operative macular oedema associated with cataract surgery: from UK NHS perspective. Value in Health 2016;19(7):A569-70. 5775110
87. NCT00407017. Therapeutic variables in cataract surgery. clinicaltrials.gov/ct2/show/NCT00407017 (accessed 5 October 2016). 5775112
88. NCT00433225. Efficacy of topical ketorolac versus placebo for improving visual outcomes following multifocal IOL implantation. clinicaltrials.gov/ct2/show/NCT00433225 (accessed 5 October 2016). 5775114
89. NCT00698724. Comparing optical coherence tomography (OCT) and visual acuity outcomes in subjects undergoing cataract surgery, who receive xibrom ophthalmic solution and standard presurgical care vs. xibrom ophthalmic solution plus prednisolone acetate 1% and standard presurgical care. clinicaltrials.gov/ct2/show/NCT00698724 (accessed 5 October 2016). 5775116
90. NCT00758199. Determination of optimum duration of treatment with bromfenac (xibrom) eyedrops following cataract surgery. clinicaltrials.gov/ct2/show/NCT00758199 (accessed 5 October 2016). 5775118
91. NCT01193504. Randomized, masked comparison of bromfenac and besifloxacin BID with either prednisolone BID or loteprednol 0.5% BID for prevention of retinal thickening and CME following phacoemulsification. clinicaltrials.gov/ct2/show/NCT01193504 (accessed 5 October 2016). 5775120
92. Nishino M, Equchi H, Iwata A, Shiota H, Tanaka M, Tanaka T. Are topical steroids essential after an uneventful cataract surgery?. Journal of Medical Investigation 2009;56(1-2):11-5. 5775122
93. Othenin-Girard P, Tritten JJ, Pittet N, Herbort CP. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. Journal of Cataract and Refractive Surgery 1994;20(1):9-12. 5775124
94. Ozkurt Y, Oral Y. Comparison of postoperative anti-inflammatory effects of ketorolac 0.5% and prednisolone 1% after phacoemulsification and intraocular lens implantation. SOE 2003: XIV Congress of the European Society of Ophthalmology 2003:305-9. 5775126
95. Pollack A, Staurenghi G, Sager D, Mukesh B, Reiser H, Singh RP. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. British Journal of Ophthalmology 2017;101:423-7. 5775128
96. Raju AS, Raju NS, Rajendran B, Paju B. Prospective randomized controlled trial between diclofenac sodium and prednisolone acetate eye drops in cataract surgery. American Academy of Ophthalmology; 2005 Oct 15-18; Chicago (IL). 2005. 5775130
97. Ramakrishnan S, Baskaran P, Talwar B, Venkatesh R. Prospective, randomized study comparing the effect of 0.1% nepafenac and 0.4% ketorolac tromethamine on macular thickness in cataract surgery patients with low risk for cystoid macular edema. Asia-Pacific Journal of Ophthalmology 2015;4(4):216-20. 5775132
98. Rocha G. A randomized, masked comparison of topical ketorolac 0.4% plus steroid alone in low-risk cataract surgery patients. Evidence-Based Ophthalmology 2009;10(2):92-3. 5775134
99. Sabiston DW, Robinson IG. An evaluation of the anti-inflammatory effect of flurbiprofen after cataract extraction. British Journal of Ophthalmology 1987;71(6):418-21. 5775136
100. Smerdon DL, Hung SO, Akingbehin T. Double-blind controlled trial to compare anti-inflammatory effects of tolmetin 2%, prednisolone 0.5%, and placebo in post-cataract extraction eyes. British Journal of Ophthalmology 1986;70(10):761-3. 5775138
101. Sourdille P, Zanlonghi X, Bron V, Allaire C, Trinquand C. Comparison of prednisolone and topical indomethacin in post-operative inflammation. European Journal of Implant and Refractive Surgery 1993;5(3):1959-63. 5775140
102. Suharwardy J, Ling C, Bell JA, Munton CG. A comparative trial between diclofenac-gentamicin and bethamethasone-neomycin drops in patients undergoing cataract extraction. Eye 1994;8(4):550-4. 5775142
103. Szymański A, Gierek-Lapińska A, Koziak M. Influence of steroidal and nonsteroidal anti-inflammatory drugs on post-operative blood-aqueous barrier in pseudophakia. Klinika Oczna 1993;96(4-5):145-7. 5775144
104. Tauber S, Gessler J, Scott W, Peterson C, Hamlet P. The effect of topical ketorolac 0.4% on cystoid macular edema following routine cataract surgery. Investigative Ophthalmology & Visual Science 2006; Vol. 47:ARVO E-Abstract 683. 5775146
105. Tunc M, Saatci OA, Ergin MH, Ergin S. Cystoid macular edema early after uncomplicated cataract surgery: the efficacy of diclofenac in prophylaxis. Annals of Ophthalmology - Glaucoma 1999;31(1):27-32. 5775148
106. Turan-Vural E, Halili E, Serin D. Assessing the effect of ketorolac and acetazolamide on macular thickness by optical coherence tomography following cataract. International Ophthalmology 2013;34(3):525-31. 5775150
107. Waseem M, Humayun S. Comparison of anti-inflammatory activity of dexamethasone and diclofenac sodium eye drops in phacoemulsification. Journal of the College of Physicians and Surgeons Pakistan 2009;19(9):570-4. 5775152
108. Yasuda K, Motohashi R, Kotake O, Nakagawa H, Noma H, Shimura M. Comparative effects of topical diclofenac and betamethasone on inflammation after vitrectomy and cataract surgery in various vitreoretinal diseases. Journal of Ocular Pharmacology and Therapeutics 2016;32(10):677-84. 5775154
109. Yung CW, Hui SL, Wang J, Gao H, Peracha MO, Pratt LM, et al. The effect of topical ketorolac tromethamine 0.5% on macular thickness in diabetic patients after cataract surgery. American Academy of Ophthalmology; 2007 Nov 10-13; New Orleans (LA). 2007. 5775156
110. ChiCTR-TRC-12002600. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. www.chictr.org.cn/showprojen.aspx?proj=6951 (accessed 5 October 2016). 5775158
111. Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, et al. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome. Journal of Cataract and Refractive Surgery 2016;42(8):1119-25. 5775160
112. Jirásková N, Rozsíval P, Liláková D, Klimešová J. Nonsteroidal anti-inflammatory agents after cataract surgery [Nesteroidní antiflogistika po operaci katarakty]. Ceská a slovenská oftalmologie : casopis Ceské oftalmologické spolecnosti a Slovenské oftalmologické spolecnosti 2000;56(3):176-9. 5775162
113. Liu SC, Wang LQ. Study on the preventive effect of 1g/L bromfenac sodium hydrate ophthalmic solution on macular edema after cataract surgery. International Eye Science 2016;16(12):2250-3. 5775164
114. Malik A, Sadafale A, Gupta YK, Gupta A. A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation. Oman Journal of Ophthalmology 2016;9(3):150-6. 5775166
115. NCT00366691. Comparison of Acular LS with Lotemax to prevent inflammation after cataract surgery and intraocular lens implantation. clinicaltrials.gov/ct2/show/NCT00366691 (accessed 16 June 2017). 5775168
116. NCT00992355. Tobramycin-dexamethasone versus tobramycin-dexamethasone plus ketorolac after phacoemulsification surgery. clinicaltrials.gov/ct2/show/NCT00992355 (accessed 16 June 2017). 5775170
117. Stringa A, Iato MS, Pasinetti GM, Reposi S. Anti-inflammatory non steroidal and steroidal drugs: their effects on postsurgical inflammation [Antiinfiammatori non steroidei e steroidei: effetti sull'infiammazione postchirurgica]. Annali Di Ottalmologia e Clinica Oculistica 1996;122:125-31. 5775172
118. NCT01774474. PRevention of Macular EDema after cataract surgery (PREMED). clinicaltrials.gov/ct2/show/NCT01774474 (accessed 16 June 2017). 5775174
119. Pollack A, Lehmann R, Staurenghi G, Narvekar A, Adewale A, Singh R. Clinical efficacy and safety of nepafenac 0.3% administered once-daily in patients with diabetic retinopathy following cataract surgery: outcomes from two identical, randomised, phase 3 studies. Ophthalmologica 2016;236:11. 5775176
120. Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. British Journal of Pharmacology 2006;148(3):245-54.
121. Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs 2007;67(9):1291-308.
122. Congdon N, Vingerling JR, Klein BE, West S, Friedman DS, Kempen J, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Archives of Ophthalmology 2004;122(4):487-94.
123. DeCroos FC, Afshari NA. Perioperative antibiotics and anti-inflammatory agents in cataract surgery. Current Opinion in Ophthalmology 2008;19(1):22-6.
124. Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR, Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology 2007;114(9):1653-62.
125. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. American Journal of Ophthalmology 1987;103(4):479-86.
126. Flach AJ, Lavelle CJ, Olander KW, Retzlaff JA, Sorenson LW. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology 1988;95(9):1279-84.
127. Flach AJ, Jampol LM, Weinberg D, Kraff MC, Yannuzzi LA, Campo RV, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. American Journal of Ophthalmology 1991;112(5):514-9.
128. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. International Ophthalmology Clinics 2002;42(1):1-11.
129. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 10 January 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
130. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmology 2001;108(5):936-44.
131. Higgins JP, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
132. Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
133. Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. Graefe's Archives of Clinical and Experimental Ophthalmology 2005;243(8):768-73.
134. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. American Journal of Ophthalmology 2005;140(3):509-16.
135. Kessel L, Tendal B, Jorgensen KJ, Erngaard D, Flesner P, Andresen JL, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 2014;121(10):1915-24.
136. Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology 2015;122(11):2159-68.
137. Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Journal of Cataract and Refractive Surgery 2007;33(1):53-8.
138. Lim BX, Lim CHL, Lim DK, Evans JR, Bunce C, Wormald R. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD006683.pub3]
139. McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Current Opinion in Ophthalmology 2000;11(1):3-6.
140. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annual Reviews in Biochemistry 1986;55(1):69-102.
141. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
142. Rossetti L, Bujtar E, Castoldi D, Torrazza C, Orzalesi N. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. Journal of Cataract and Refractive Surgery 1996;22(Suppl 1):794-9.
143. Sharir M. Exacerbation of asthma by topical diclofenac. Archives of Ophthalmology 1997;115(2):294-5.
144. Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004239.pub3]
145. Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. Cataract and Refractive Surgery 2000;26(8):1225-7.
146. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Journal of Cataract and Refractive Surgery 1995;21(1):73-81.
147. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scandinavian Journal of Rheumatology, Supplement 1996;25(Suppl 102):9-21.
148. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflammation Research 1998;47(2):S78-S87.
149. Wielders LH, Lambermont VA, Schouten JS, van den Biggelaar FJ, Worthy G, Simmons RW, et al. Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. American Journal of Ophthalmology 2016;160(5):968-81.
150. Gonzales JA, Gritz DC, Channa R, Quinto GG, Kim A, Chuck RS. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD010516]